177
Views
1
CrossRef citations to date
0
Altmetric
Original Investigations

Metabolic syndrome components and leukocyte telomere length in patients with major depressive disorder

, , , , , & show all
Pages 483-492 | Received 31 Aug 2020, Accepted 29 Nov 2021, Published online: 16 Dec 2021

References

  • Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC. Jr. International Association for the Study of Obesity 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation. 120(16):1640–1645.
  • Allsopp RC, Harley CB. 1995. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res. 219(1):130–136.
  • Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB. 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 89(21):10114–10118.
  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association.
  • Bekaert S, De Meyer T, Van Oostveldt P. 2005. Telomere attrition as ageing biomarker. Anticancer Res. 25(4):3011–3021.
  • Blackburn EH. 2001. Switching and signaling at the telomere. Cell. 106(6):661–673.
  • Block A, Schipf S, Van der Auwera S, Hannemann A, Nauck M, John U, Volzke H, Freyberger HJ, Dorr M, Felix S, et al. 2016. Sex- and age-specific associations between major depressive disorder and metabolic syndrome in two general population samples in Germany. Nord J Psychiatry. 70(8):611–620.
  • Brown ES, Varghese FP, McEwen BS. 2004. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry. 55(1):1–9.
  • Cawthon RM. 2009. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 37(3):e21.
  • Chen W, Gardner JP, Kimura M, Brimacombe M, Cao X, Srinivasan SR, Berenson GS, Aviv A. 2009. Leukocyte telomere length is associated with HDL cholesterol levels: The Bogalusa Heart Study. Atherosclerosis. 205(2):620–625.
  • Chen YF, Zhou KW, Yang GZ, Chen C. 2019. Association between lipoproteins and telomere length in US adults: data from the NHANES 1999–2002. Lipids Health Dis. 18(1):80.
  • Chou FH, Chou P, Su TT, Ou-Yang WC, Chien IC, Lu MK, Huang MW. 2004. Quality of life and related risk factors in a Taiwanese village population 21 months after an earthquake. Aust N Z J Psychiatry. 38(5):358–364.
  • Ferrari AJ, Charlson FJ, Norman RE, Flaxman AD, Patten SB, Vos T, Whiteford HA. 2013. The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS One. 8(7):e69637.
  • Foley DL, Morley KI, Madden PA, Heath AC, Whitfield JB, Martin NG. 2010. Major depression and the metabolic syndrome. Twin Res Hum Genet. 13(4):347–358.
  • Galie S, Canudas S, Muralidharan J, Garcia-Gavilan J, Bullo M, Salas-Salvado J. 2020. Impact of nutrition on telomere health: systematic review of observational cohort studies and randomized clinical trials. Adv Nutr. 11(3):576–601.
  • Grover S, Nebhinani N, Chakrabarti S, Avasthi A, Kulhara P. 2013. Metabolic syndrome in drug-naïve patients with depressive disorders. Indian J Psychol Med. 35(2):167–173.
  • Hammen C. 2005. Stress and depression. Annu Rev Clin Psychol. 1:293–319.
  • Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M. 2006. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study. Psychosom Med. 68(2):213–216.
  • Huzen J, Wong LSM, Veldhuisen DJ, Samani NJ, Zwinderman AH, Codd V, Cawthon RM, Benus GFJD, Horst ICC, Navis G, et al. 2014. Telomere length loss due to smoking and metabolic traits. J Intern Med. 275(2):155–163.
  • Kajstura J, Rota M, Urbanek K, Hosoda T, Bearzi C, Anversa P, Bolli R, Leri A. 2006. The telomere-telomerase axis and the heart. Antioxid Redox Signal. 8(11–12):2125–2141.
  • Kessler RC, Merikangas KR, Wang PS. 2007. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol. 3(1):137–158.
  • Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. 2004. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med. 66(3):316–322.
  • Kinser PA, Lyon DE. 2013. Major depressive disorder and measures of cellular aging: an integrative review. Nurs Res Pract. 2013:469070.
  • Lehto SM, Hintikka J, Niskanen L, Tolmunen T, Koivumaa-Honkanen H, Honkalampi K, Viinamaki H. 2008. Low HDL cholesterol associates with major depression in a sample with a 7-year history of depressive symptoms. Prog Neuropsychopharmacol Biol Psychiatry. 32(6):1557–1561.
  • Lin J, Epel E, Cheon J, Kroenke C, Sinclair E, Bigos M, Wolkowitz O, Mellon S, Blackburn E. 2010. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods. 352(1–2):71–80.
  • Lin PY, Huang YC, Hung CF. 2016. Shortened telomere length in patients with depression: a meta-analytic study. J Psychiatr Res. 76:84–93.
  • Lin KP, Liang TL, Liao IC, Tsay SL. 2014. Associations among depression, obesity, and metabolic syndrome in young adult females. Biol Res Nurs. 16(3):327–334.
  • Liu RT, Alloy LB. 2010. Stress generation in depression: A systematic review of the empirical literature and recommendations for future study. Clin Psychol Rev. 30(5):582–593.
  • Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. 2013. The hallmarks of aging. Cell. 153(6):1194–1217.
  • Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, Demedts P, Wauters A, Meltzer HY. 1997. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand. 95(3):212–221.
  • Mishra M, Muthuramu I, De Geest B. 2019. HDL dysfunction, function, and heart failure. Aging. 11(2):293–294.
  • Monickaraj F, Aravind S, Gokulakrishnan K, Sathishkumar C, Prabu P, Prabu D, Mohan V, Balasubramanyam M. 2012. Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem. 365(1–2):343–350.
  • Moreira FP, Jansen K, Cardoso TA, Mondin TC, Magalhaes P, Kapczinski F, Souza LDM, da Silva RA, Oses JP, Wiener CD. 2017. Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: population-based study: metabolic syndrome in current depressive episode. J Psychiatr Res. 92:119–123.
  • Moreira FP, Jansen K, Cardoso TA, Mondin TC, Vieira IS, Magalhaes P, Kapczinski F, Souza LDM, da Silva RA, Oses JP, et al. 2019. Metabolic syndrome, depression and anhedonia among young adults. Psychiatry Res. 271:306–310.
  • Musselman DL, Evans DL, Nemeroff CB. 1998. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 55(7):580–592.
  • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2002. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 106(25):3143–3421.
  • Olden M, Rosenfeld B, Pessin H, Breitbart W. 2009. Measuring depression at the end of life: is the Hamilton Depression Rating Scale a valid instrument? Assessment. 16(1):43–54.
  • Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF, Jr., Meigs JB, Lipinska I, Kathiresan S, et al. 2007. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 116(11):1234–1241.
  • Radler BT, Rigotti A, Ryff CD. 2018. Persistently high psychological well-being predicts better HDL cholesterol and triglyceride levels: findings from the midlife in the U.S. (MIDUS) longitudinal study. Lipids Health Dis. 17(1):1.
  • Rehkopf DH, Needham BL, Lin J, Blackburn EH, Zota AR, Wojcicki JM, Epel ES. 2016. Leukocyte telomere length in relation to 17 biomarkers of cardiovascular disease risk: a cross-sectional study of US adults. PLOS Med. 13(11):e1002188.
  • Revesz D, Milaneschi Y, Verhoeven JE, Lin J, Penninx BW. 2015. Longitudinal associations between metabolic syndrome components and telomere shortening. J Clin Endocrinol Metab. 100(8):3050–3059.
  • Revesz D, Milaneschi Y, Verhoeven JE, Penninx BW. 2014. Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome. J Clin Endocrinol Metab. 99(12):4607–4615.
  • Revesz D, Verhoeven JE, Picard M, Lin J, Sidney S, Epel ES, Penninx B, Puterman E. 2018. Associations Between Cellular Aging Markers and Metabolic Syndrome: Findings From the CARDIA Study. J Clin Endocrinol Metab. 103(1):148–157.
  • Ridout KK, Ridout SJ, Price LH, Sen S, Tyrka AR. 2016. Depression and telomere length: a meta-analysis. J Affect Disord. 191:237–247.
  • Satoh M, Ishikawa Y, Takahashi Y, Itoh T, Minami Y, Nakamura M. 2008. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis. 198(2):347–353.
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59(Suppl 20):22–57.
  • Skilton MR, Moulin P, Terra JL, Bonnet F. 2007. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry. 62(11):1251–1257.
  • Thomas MD, Sohail S, Mendez RM, Marquez-Magana L, Allen AM. 2021. Racial discrimination and telomere length in midlife African American women: interactions of educational attainment and employment status. Ann Behav Med. 55(7): 601–611.
  • Vancampfort D, Correll CU, Wampers M, Sienaert P, Mitchell AJ, De Herdt A, Probst M, Scheewe TW, De Hert M. 2014. Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychol Med. 44(10):2017–2028.
  • Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, Rosenbaum S, Correll CU. 2015. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 14(3):339–347.
  • Verhoeven JE, Revesz D, Epel ES, Lin J, Wolkowitz OM, Penninx BW. 2014. Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol Psychiatry. 19(8):895–901.
  • Vincent J, Hovatta I, Frissa S, Goodwin L, Hotopf M, Hatch SL, Breen G, Powell TR. 2017. Assessing the contributions of childhood maltreatment subtypes and depression case-control status on telomere length reveals a specific role of physical neglect. J Affect Disord. 213:16–22.
  • Virtanen M, Ferrie JE, Akbaraly T, Tabak A, Jokela M, Ebmeier KP, Singh-Manoux A, Kivimaki M. 2017. Metabolic syndrome and symptom resolution in depression: a 5-year follow-up of older adults. J Clin Psychiatry. 78(1):e1–e7.
  • Vogelzangs N, Beekman AT, Dik MG, Bremmer MA, Comijs HC, Hoogendijk WJ, Deeg DJ, Penninx BW. 2009. Late-life depression, cortisol, and the metabolic syndrome. Am J Geriatr Psychiatry. 17(8):716–721.
  • Wu KY, Lin KJ, Chen CH, Chen CS, Liu CY, Huang SY, Yen TC, Hsiao IT. 2018. Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: evidence of cerebral amyloidosis and hippocampal atrophy. Brain Behav. 8(7):e01016.
  • Zhang C, Yang Y, Zhu DM, Zhao W, Zhang Y, Zhang B, Wang Y, Zhu J, Yu Y. 2020. Neural correlates of the association between depression and high density lipoprotein cholesterol change. J Psychiatr Res. 130:9–18.
  • Zhao J, Zhu Y, Uppal K, Tran VT, Yu T, Lin J, Matsuguchi T, Blackburn E, Jones D, Lee ET, et al. 2014. Metabolic profiles of biological aging in American Indians: the Strong Heart Family Study. Aging. 6(3):176–186.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.